Hypertrophic Cardiomyopathy With Elongated Mitral Valve Leaflets: Clinical Characteristics and Surgical Results

被引:0
|
作者
Liu, Xianying [1 ]
Mcgrath, Daniel [2 ]
Ohlrich, Kelly [3 ]
Chen, Frederick Y. [4 ]
Lee, Lawrence S. [4 ]
Robich, Michael [5 ]
机构
[1] Oregon Hlth & Sci Univ, Dept Anesthesiol, Portland, OR USA
[2] Columbia Univ, Stamford Hosp, Dept Surg, Stamford, CT USA
[3] Med Univ South Carolina, Dept Cardiothorac Surg, Charleston, SC USA
[4] Tufts Med Ctr, Dept Cardiac Surg, Boston, MA USA
[5] John Hopkins Med, Div Cardiac Surg, Baltimore, MD 21224 USA
关键词
elongated mitral valve leaflets; hypertrophic cardiomyopathy; mitral valve plication; septal myectomy; MYECTOMY;
D O I
10.1155/2024/7078246
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Hypertrophic cardiomyopathy (HCM) is commonly associated with mitral valve pathology. A large majority of patients with HCM have elongated anterior and posterior mitral leaflets. There remains debate regarding the necessity and role of concomitant mitral valve surgery at the time of septal myectomy. We aimed to describe the characteristics and share our surgical experiences with this specific group of patients.Methods: This retrospective single-center study investigates adult patients with HCM, with or without elongated mitral valve leaflets (MVLs), who underwent elective septal myectomy with or without concomitant mitral valve intervention, between January 1, 2016, and June 30, 2020. Clinical data were obtained from institutional medical records as well as the Society of Thoracic Surgeons data registry. The clinical characteristics and in-hospital surgical outcomes were compared between patients with an elongated MVL and those without.Results: In total, 379 patients underwent septal myectomy, and 22 patients with intrinsic mitral valve disease were excluded. In addition, 23 patients were excluded due to missing data. Of the remaining 334 patients, 131 (39.2%) had elongated MVL and concomitant MVL plication. Patients with elongated MVL had higher rates of preoperative mitral valve systolic anterior motion (SAM) (94.7% vs. 86.7%, p=0.019) and higher preoperative provoked left ventricular outflow tract gradient (LVOTG) (134.5 mmHg versus 125.3 mmHg, p=0.046). Post septal myectomy and mitral valve plication, they had lower rates of postoperative residual mitral regurgitation (3.8% vs. 12.8%, p=0.006), comparable rates of residual SAM (28.2% vs. 31.5%, p = 0.524), postoperative provoked LVOTG (15.4 mmHg vs. 14.0 mmHg, p=0.317), 30-day major adverse cardiopulmonary events (2.3% vs. 3.9%, p=0.409), and mortality (0% vs. 1.0%, p=0.255).Conclusions: Elongated MVLs contribute more significantly to dynamic LVOT obstruction, as evidenced during provocative testing. Concomitant mitral valve intervention during septal myectomy can be performed safely and may provide an effective strategy to resolve SAM and stress-induced LVOTG.
引用
收藏
页数:6
相关论文
共 50 条
  • [1] Is mitral valve leaflets elongation genetically transmitted in familial hypertrophic cardiomyopathy?
    Hagege, AA
    Mirochnik, N
    Dubourg, O
    Desnos, M
    Isnard, R
    Carrier, L
    CIRCULATION, 1997, 96 (08) : 3610 - 3610
  • [2] Percutaneous versus surgical treatment for patients with hypertrophic obstructive cardiomyopathy and enlarged anterior mitral valve leaflets
    van der Lee, C
    ten Cate, FJ
    Geleijnse, ML
    Kofflard, MJ
    Pedone, C
    van Herwerden, LA
    Biagini, E
    Vletter, WB
    Serruys, PW
    CIRCULATION, 2005, 112 (04) : 482 - 488
  • [3] Hypertrophic cardiomyopathy with latent obstruction: Clinical characteristics and surgical results
    Ji, Qiang
    Wang, YuLin
    Liu, FangYu
    Yang, Ye
    Xia, LiMin
    Ding, WenJun
    Lai, Hao
    Wang, ChunSheng
    JOURNAL OF CARDIOLOGY, 2022, 79 (01) : 42 - 49
  • [4] NEW OBSERVATIONS ON SYSTOLIC ANTERIOR MOTION OF MITRAL-VALVE LEAFLETS IN HYPERTROPHIC CARDIOMYOPATHY
    GEHRKE, J
    BRITISH HEART JOURNAL, 1976, 38 (03): : 314 - 314
  • [5] The Mitral Valve in Hypertrophic Cardiomyopathy
    Hagege, Albert A.
    Bruneval, Patrick
    Levine, Robert A.
    Desnos, Michel
    Neamatalla, Hany
    Judge, Daniel P.
    JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH, 2011, 4 (06) : 757 - 766
  • [6] The mitral valve in hypertrophic cardiomyopathy
    Malcolmson, James
    Shipolini, Alex
    Mohiddin, Saidi
    Savvatis, Konstantinos
    CURRENT OPINION IN CARDIOLOGY, 2023, 38 (05) : 415 - 423
  • [7] Role of Mitral Valve Plication in the Surgical Management of Hypertrophic Cardiomyopathy
    Balaram, Sandhya K.
    Ross, Ronald E.
    Sherrid, Mark V.
    Schwartz, Gary S.
    Hillel, Zak
    Winson, Glenda
    Swistel, Daniel G.
    ANNALS OF THORACIC SURGERY, 2012, 94 (06): : 1990 - 1998
  • [8] Surgical treatment of obstructive hypertrophic cardiomyopathy: the role of mitral valve
    Raffa, Giuseppe M.
    Romano, Giuseppe
    Falletta, Calogero
    Morsolini, Marco
    Turrisi, Marco
    Gentile, Giovanni
    Nugara, Cinzia
    Scarlata, Maria
    Clemenza, Francesco
    Pilato, Michele
    GIORNALE ITALIANO DI CARDIOLOGIA, 2019, 20 (02) : 109 - 116
  • [9] Characteristics and Surgical Results of Patients with Hypertrophic Obstructive Cardiomyopathy without Intrinsic Mitral Valve Diseases Undergoing Mitral Subvalvular Procedures during Myectomy
    Ji, Qiang
    Wang, YuLin
    Yang, Ye
    Xia, LiMin
    Ding, WenJun
    Song, Kai
    Wang, ChunSheng
    CARDIOLOGY RESEARCH AND PRACTICE, 2020, 2020
  • [10] Direct insertion of papillary muscle into mitral valve leaflets in a healthy patient without hypertrophic cardiomyopathy
    Jose Lepori, Augusto
    Jose Lepori, Orlando
    Werenitzky, Jose
    Islas, Fabian
    Perez de Isla, Lepoldo
    ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES, 2019, 36 (06): : 1217 - 1218